NCT02212626View on ClinicalTrials.gov

Prospective, Non-randomized Multi-center, Controlled Physician-initiated Trial: Rotarex Belgium In-stent Occlusion

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions

Peripheral Vascular Disease

Interventions

DEVICE

Rotarex S

Trial Locations (5)

2650

UZA, Edegem

2820

Imelda Hospital, Bonheiden

3300

RZ Heilig Hart Hospital, Tienen

9200

AZ Sint-Blasius, Dendermonde

9300

OLV Hospital, Aalst

All Listed Sponsors

lead

Flanders Medical Research Program

NETWORK

NCT02212626 - Prospective, Non-randomized Multi-center, Controlled Physician-initiated Trial: Rotarex Belgium In-stent Occlusion | Biotech Hunter | Biotech Hunter